GlaxoSmithKline plc  

(Public, LON:GSK)   Watch this stock  
Find more results for GSK
1,473.00
-16.00 (-1.07%)
Apr 29 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1,458.56 - 1,482.50
52 week 1,227.50 - 1,576.29
Open 1,480.00
Vol / Avg. 0.00/7.80M
Mkt cap 71.75B*
P/E 8.44
Div/yield 23.00*
EPS 1.75*
Shares 4.87B
Beta     -
Inst. own     -
*GBP
Jul 27, 2016
Q2 2016 GlaxoSmithKline PLC Earnings Release Add to calendar
May 6, 2016
GlaxoSmithKline PLC Annual Shareholders Meeting (Estimated) - 2:30PM GMT+1 - Add to calendar
May 5, 2016
GlaxoSmithKline PLC Annual Shareholders Meeting - 2:30PM GMT+1 - Add to calendar
Apr 27, 2016
Q1 2016 GlaxoSmithKline PLC Earnings Call
Apr 27, 2016
Q1 2016 GlaxoSmithKline PLC Earnings Release
Mar 1, 2016
GlaxoSmithKline PLC at Credit Suisse One-on-One Healthcare Conference
Feb 10, 2016
GlaxoSmithKline PLC at Leerink Partners Global Healthcare Conference
Feb 3, 2016
Q4 2015 GlaxoSmithKline PLC Earnings Call
Feb 3, 2016
Q4 2015 GlaxoSmithKline PLC Earnings Release
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -6.81% 35.00%
Operating margin -4.02% 46.67%
EBITD margin - 32.04%
Return on average assets -3.22% 17.79%
Return on average equity -26.93% 179.63%
Employees 101,192 -
CDP Score - 100 B

Address

980 Great West Road
BRENTFORD, TW8 9GS
United Kingdom - Map
+44-20-80475000 (Phone)
+44-20-80477807 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK's Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSK's Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Officers and directors

Andrew Philip Witty Chief Executive Officer, Executive Director
Age: 50
Simon Dingemans Chief Financial Officer, Executive Director
Age: 51
Moncef Slaoui Chairman - Global Vaccines, Executive Director
Age: 55
Roger Connor President - Global Manufacturing & Supply
Abbas Hussain President, Global Pharmaceuticals
Shah Abbas Hussain President - Europe, Japan & EMAP
Age: 49
Patrick Vallance President - Pharmaceuticals R&D
Emma Walmsley President - Consumer Healthcare Worldwide
Daniel Troy Senior Vice President, General Counsel
Claire Thomas Senior Vice President - Human Resources